Skip Navigation

Profile

Adrian W. Laxton, M.D.Wake Forest Baptist Health

Doctor Rating

4.8 out of 5

104 Ratings
17 Comments
 

Adrian W. Laxton, M.D.

Assistant Professor,

Clinical Interests

Epilepsy, Movement Disorders, Neurosurgery, Deep Brain Stimulation, Radiosurgery, Brain Tumors, Trigeminal Neuralgia

Contact Information

Department: 336-716-4081

Insurance Accepted »

Related Links

Education & Training

  • M.A., Queen's University Ontario-Canada, 1998
  • M.D., University Toronto Med-Canada, 2002
  • Fellowship, University Toronto Med-Canada, 2009
  • Residency, Neurosurgery, Univ. of Toron Affl Hosp, 2011
  • Fellowship, University Toronto Med-Canada, 2012

Board Certifications

  • Royal College Physicians and Surgeons Canada, Neurosurgery

Memberships

  • Am Assn Of Neurological Surgeo
  • Congress Of Neurological Surge

NPI Number

  • 1063764140
Adrian W. Laxton, M.D.

Doctor Rating

4.8 out of 5

104 Ratings
17 Comments
 

Adrian W. Laxton, M.D.

Assistant Professor, Neurosurgery

Research Interests

Deep Brain Stimulation; Radiosurgery; Alzheimer Disease; Parkinson Disease; Brain Neoplasms
More »

Contact Information

Academic: 336-716-6438 | Department: 336-716-4081

Related Links

Recent Publications

The protective action encoding of serotonin transients in the human brain. Moran RJ, Kishida KT, Lohrenz T, Saez I, Laxton AW, Witcher MR, Tatter SB, Ellis TL, Phillips PE, Dayan P, Montague PR.. Neuropsychopharmacology. 2018;43(6):1425-1435.

Emerging indications for fractionated gamma knife radiosurgery. McTyre E, Helis CA, Farris M, Wilkins L, Sloan D, Hinson WH, Bourland JD, Dezarn WA, Munley MT, Watabe K, Xing F, Laxton AW, Tatter SB, Chan MD.. Neurosurgery. 2017;80(2):210-216.

Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. McKay WH, McTyre ER, Okoukoni C, Alphonse-Sullivan NK, Ruiz J, Munley MT, Qasem S, Lo HW, Xing F, Laxton AW, Tatter SB, Watabe K, Chan MD.. J Neurosurg. 2017;127(1):148-156.

Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy. McTyre ER, Johnson AG, Ruiz J, Isom S, Lucas JT Jr, Hinson WH, Watabe K, Laxton AW, Tatter SB, Chan MD.. Neuro Oncol. 2017;19(4):558-566.

Gamma Knife radiosurgery for brain metastases from gastrointestinal primary. Page BR, Wang EC, White L, McTyre E, Peiffer A, Alistar A, Mu F, Loganathan A, Bourland JD, Laxton AW, Tatter SB, Chan MD.. J Med Imaging Radiat Oncol. 2017;61(4):522-527.

Outcomes for anaplastic glioma treated with radiation therapy with or without concurrent temozolomide. McTyre E, Lucas JT, Helis C, Farris M, Soike M, Mott R, Laxton AW, Tatter SB, Lesser GJ, Strowd RE, Lo HW, Debinski W, Chan MD.. Am J Clin Oncol. 2017;():.

The effects of smoking status and smoking history on patients with brain metastases from lung cancer. Shenker RF, McTyre ER, Ruiz J, Weaver KE, Cramer C, Alphonse-Sullivan NK, Farris M, Petty WJ, Bonomi MR, Watabe K, Laxton AW, Tatter SB, Warren GW, Chan MD.. Cancer Med. 2017;6(5):944-952.

Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases. Wang EC, Huang AJ, Huang KE, McTyre ER, Lo HW, Watabe K, Metheny-Barlow L, Laxton AW, Tatter SB, Strowd RE, Chan MD, Page BR.. J Clin Neurosci. 2017;43():6-10.

Surgical considerations in the optimal management of patients with malignant brain tumors. Renfrow JJ, Strowd RE, Laxton AW, Tatter SB, Geer CP, Lesser GJ.. Curr Treat Options Oncol. 2017;18(8):46.

Stereotactic radiosurgery in the treatment of brain metastases from gynecologic primary cancer. Johnston H, McTyre ER, Cramer CK, Lesser GJ, Ruiz J, Bourland JD, Watabe K, Lo HW, Qasem S, Laxton AW, Tatter SB, Chan MD.. J Radiosurg SBRT. 2017;5(1):55-61.

Impact of radiosurgical management of geriatric patients with brain metastases: clinical and quality of life outcomes. Randolph DM, McTyre E, Klepin H, Peiffer AM, Ayala-Peacock D, Lester S, Laxton AW, Dohm A, Tatter SB, Shaw EG, Chan MD.. J Radiosurg SBRT. 2017;5(1):35-42.

Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: clinical outcomes and local control. Dohm A, McTyre ER, Chan MD, Fan C, Isom S, Bourland JD, Mott RT, Cramer CK, Tatter SB, Laxton AW.. J Clin Neurosci. 2017;46():90-98.

Staged stereotactic radiosurgery for large brain metastases: local control and clinical outcomes of a one-two punch technique. Dohm A, McTyre ER, Okoukoni C, Henson A, Cramer CK, LeCompte MC, Ruiz J, Munley MT, Qasem S, Lo HW, Xing F, Watabe K, Laxton AW, Tatter SB, Chan MD.. Neurosurgery. 2017;():.

Clinical outcomes of upfront stereotactic radiosurgery alone for patients with greater than 4 brain metastases [abstract]. Hughes RT, McTyre E, LeCompte MC, Cramer CK, Munley MT, Laxton A, Tatter SB, Ruiz J, Pasche B, Watabe K, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E80-E81.

Survival and failure outcomes predicted by brain metastasis kinetics following initial distant brain failure in melanoma patients treated upfront with stereotactic radiosurgery alone [abstract]. LeCompte MC, McTyre E, Henson A, Farris M, Okoukoni C, Cramer CK, Triozzi P, Munley MT, Qasem S, Xing F, Watabe K, Laxton A, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E86-E87.

Drivers of the cost of management in patients treated with radiosurgery without whole brain radiation therapy for brain metastases [abstract]. Shenker RF, McTyre E, Cramer CK, Munley MT, Ruiz J, Watabe K, Pasche B, Laxton A, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E414-E415.

Stereotactic radiosurgery for multiple sclerosis associated trigeminal neuralgia [abstract]. Helis CA, McTyre E, Munley MT, Bourland JD, Cramer CK, Laxton A, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E512-E513.

Initial brain metastasis velocity: does the rate at which cancers first seed the brain affect outcomes? [abstract]. Soike M, McTyre E, Farris M, Hughes RT, Cramer CK, LeCompte MC, Ruiz J, Bourland JD, Munley MT, Laxton A, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):S170.

Sociodemographic predictors of patients with brain metastases treated with stereotactic radiosurgery. Alphonse-Sullivan N, Taksler GB, Lycan T, Weaver KE, McTyre ER, Shenker RF, Page BR, Isom S, Johnson A, Munley MT, Laxton AW, Tatter SB, Watabe K, Chan MD, Ruiz J.. Oncotarget. 2017;8(60):101055-11.

The number of prior lines of systemic therapy as a prognostic factor for patients with brain metastases treated with stereotactic radiosurgery: results of a large single institution retrospective analysis. Lanier CM, McTyre E, LeCompte M, Cramer CK, Hughes R, Watabe K, Lo HW, O'Neill S, Munley MT, Laxton AW, Tatter SB, Ruiz J, Chan MD.. Clin Neurol Neurosurg. 2017;165():24-28.

Survival and failure outcomes predicted by brain metastasis volumetric kinetics in melanoma patients following upfront treatment with stereotactic radiosurgery alone. LeCompte MC, McTyre E, Henson A, Farris M, Okoukoni C, Cramer CK, Triozzi P, Ruiz J, Watabe K, Lo HW, Munley MT, Laxton AW, Tatter SB, Zhou X, Chan M.. Cureus. 2017;9(12):1-12.

Subsecond dopamine fluctuations in human striatum encode superposed error signals about actual and counterfactual reward. Kishida KT, Saez I, Lohrenz T, Witcher MR, Laxton AW, Tatter SB, White JP, Ellis TL, Phillips PE, Montague PR... Proc Natl Acad Sci U S A. 2016;113(1):200-205.

Brain metastasis velocity: a novel prognostic metric predictive of overall survival and freedom from whole-brain radiation therapy after upfront radiosurgery alone for brain metastases [abstract]. Farris M, McTyre E, Hughes RT, Ayala-Peacock DN, Randolph DM II, Bourland JD, Tatter SB, Laxton AW, Watabe K, Ruiz J, Li W, Zhou X, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):S180.

Outcomes for metastatic melanoma treated with stereotactic radiosurgery in the era of targeted systemic therapies [abstract]. Henson A, McTyre E, Ayala-Peacock DN, Triozzi P, Savage P, Laxton AW, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E135-E136.

Genomic predictors of imaging response and survival in glioblastoma [abstract]. Soike M, McTyre E, Holmes JA, Paulsson AK, Miller L, Lesser GJ, Strowd RE, Johnson A, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E121-E122.

Local control of brain metastases after stereotactic radiosurgery: the impact of whole brain radiotherapy and treatment paradigm. Hughes RT, Black PJ, Page BR, Lucas JT, Qasem SA, Watabe K, Ruiz J, Laxton AW, Tatter SB, Debinski W, Chan MD.. J Radiosurg SBRT. 2016;4(2):89-96.

Predictors of trigeminal nerve dysfunction following stereotactic radiosurgery for trigeminal neuralgia. Lucas JT, Huang AJ, Bourland JD, Laxton AW, Tatter SB, Chan MD.. J Radiosurg SBRT. 2016;4(2):117-123.

Laser interstitial thermal therapy for mesial temporal lobe epilepsy. Wicks RT, Jermakowicz WJ, Jagid JR, Couture DE, Willie JT, Laxton AW, Gross RE.. Neurosurgery. 2016;79(Suppl 1):S83-S91.

Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma. Randolph DM II, McTyre ER, Paulsson AK, Holmes JA, Hinson WH, Lesser GJ, Strowd R, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD.. Clin Neurol Neurosurg. 2016;151():73-78.

Upfront chemoradiotherapy in grade 2 low grade glioma, a single institution experience [abstract]. Wicks RT, Bandarage D, Mott RT, Strowd RE, Laxton AW, Tatter SB, Chan MD, Lesser GJ.. Neuro Oncol. 2016;18(Suppl 6):14.

Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis. Mu F, Lucas JT Jr, Watts JM, Johnson AJ, Daniel Bourland J, Laxton AW, Chan MD, Tatter SB.. J Clin Neurosci. 2015;22(3):561-565.

Deep brain stimulation influences brain structure in Alzheimer's Disease. Sankar T, Chakravarty MM, Bescos A, Lara M, Obuchi T, Laxton AW, McAndrews MP, Tang-Wai DF, Workman CI, Smith GS, Lozano AM.. Brain Stimul. 2015;8(3):645-654.

Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2. Liu A, Kuhn EN, Lucas JT Jr, Laxton AW, Tatter SB, Chan MD.. J Neurosurg. 2015;122(3):536-542.

Competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage after whole-brain radiation therapy failure: who actually dies of their brain metastases?. Lucas JT Jr, Colmer HG IV, White L, Fitzgerald N, Isom S, Bourland JD, Laxton AW, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2015;92(5):1008-1015.

Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, McTyre ER, Houseknecht KW, Ayala-Peacock DN, Bourland DJ, Hinson WH, Laxton AW, Tatter SB, Debinski W, Watabe K, Chan MD.. Oncotarget. 2015;6(22):18945-55.

Repeat radiosurgery for trigeminal neuralgia. Helis CA, Lucas JT Jr, Bourland JD, Chan MD, Tatter SB, Laxton AW.. Neurosurgery. 2015;77(5):755-761.

Immunologic response to high-dose influenza vaccination in patients with primary central nervous system malignancy (PCNSM) [abstract]. Strowd RE, Russell G, Harmon M, Carter AF, Chan MD, Tatter SB, Laxton AW, High K, Lesser G.. J Clin Oncol. 2015;33(15 Suppl):e20669.

Factors that determine local control with gamma knife radiosurgery: the role of primary histology. Black PJ, Page BR, Lucas JT Jr, Hughes RT, Laxton AW, Tatter SB, Munley MT, Chan MD.. J Radiosurg SBRT. 2015;3(4):281-286.

Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field design. Holmes JA, Paulsson AK, Page BR, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD.. J Neurooncol. 2015;124(3):447-453.

A competing risks analysis assessing predictors of neurologic and non-neurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy [abstract]. McTyre E, Johnson A, Ruiz J, Isom S, Lucas JT Jr, Hinson W, Watabe K, Laxton AW, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):S176.

Outcomes for anaplastic glioma treated with radiation therapy with or without concurrent temozolomide [abstract]. McTyre E, Lucas JT Jr, Helis C, Farris M, Houseknecht K, Mott R, Laxton AW, Tatter SB, Lesser GJ, Chan MD.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E108.

Impact of socioeconomic status on brain metastasis outcomes at a large academic radiosurgery center [abstract]. Houseknecht K, Taksler GB, Johnson A, Page BR, Hinson W, Laxton AW, Tatter SB, Weaver KE, Chan MD, Ruiz J.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E366.

Comparison of stereo-EEG and grid-implanted phase II patients' experience prior to epilspsy surgery: the Wake Forest experience [abstract]. Woodard V, Boggs J, Couture D, Laxton A, Popli G, Silvia M, Sam M, Munger-Clary H, Wong M, O'Donovan C.. In: Abstracts of the 2016 Annual Meeting of the American Epilepsy Society; 2016 Dec 2-6; Houston (TX). 2015;():A2.171.

The clinical features of periorbital ecchymosis in a series of trauma patients. Somasundaram A, Laxton AW, Perrin RG.. Injury. 2014;45(1):203-205.

Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery. Lester SC, Taksler GB, Kuremsky JG, Lucas JT Jr, Ayala-Peacock DN, Randolph DM II, Bourland JD, Laxton AW, Tatter SB, Chan MD.. Cancer. 2014;120(3):433-441.

Predictive nomogram for the durability of pain relief from gamma knife radiation surgery in the treatment of trigeminal neuralgia. Lucas JT Jr, Nida AM, Isom S, Marshall K, Bourland JD, Laxton AW, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2014;89(1):120-126.

A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. Ayala-Peacock DN, Peiffer AM, Lucas JT, Isom S, Kuremsky JG, Urbanic JJ, Bourland JD, Laxton AW, Tatter SB, Shaw EG, Chan MD.. Neuro Oncol. 2014;16(9):1283-1288.

Neuronal oscillations in Parkinson's disease. Witcher M, Moran R, Tatter SB, Laxton AW.. Front Biosci (Landmark Ed). 2014;19():1291-1299.

Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma. Paulsson AK, Holmes JA, Peiffer AM, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD.. J Neurooncol. 2014;119(2):429-435.

Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery. Huang AJ, Huang KE, Page BR, Ayala-Peacock DN, Lucas JT Jr, Lesser GJ, Laxton AW, Tatter SB, Chan MD.. J Neurooncol. 2014;120(1):163-169.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Assistant Professor, Neurosurgery

Clinical Interests

Epilepsy, Movement Disorders, Neurosurgery, Deep Brain Stimulation, Radiosurgery, Brain Tumors, Trigeminal Neuralgia
Adrian W. Laxton, M.D.

Adrian W. Laxton, M.D.

Assistant Professor, Neurosurgery

Doctor Rating

4.8 out of 5

Adrian W. Laxton, M.D.104 Ratings
17 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.9
CP spoke using clear language
4.9
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.9
Patients' confidence in CP
4.9
Time CP spent with patient
4.8
Wait time at clinic
4.5



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

3/24/2018

Dr. Laxton is the most prepared provider I have encountered. He is aware of my medical condition before he enters the treatment room.

3/1/2018

Excellent experience, very knowledgeable providers who cared!

2/28/2018

Dr. Laxton was amazing!!! He sat and explained EVERYTHING in detail and went over all of my concerns. He showed me his findings and explained what I was seeing. I couldn't have asked for a better neurosurgeon ever!

2/27/2018

It was great

2/13/2018

I will definitely (have already) recommend *Dr. Laxton and WF Hospital system.

2/4/2018

We have a friend who is on staff and he said that if he or a member of his family were found with the same condition, he would request *Dr. Laxton & C_____.

12/13/2017

Dr Laxton was very clear, explaining my options. I appreciated that he took my wants and needs in to consideration.

11/20/2017

very good doctor and staff

11/15/2017

It could not have been better.

10/9/2017

I would definitely recommend this doctor and the rest of my care team

9/11/2017

This is a great doctor, he explains things like a teacher speaking to a student

8/21/2017

*Dr. Laxton explained in detail the MRI & showed to me on screen - 5. No medicine.

6/29/2017

Dr. Laxton and his team are wonderful! I hope he can do all and any future surgeries I need for my DBS stimulator.

6/26/2017

Very professional & compassionate.

5/29/2017

The care provider was very professional and had a very good bedside manner.

5/22/2017

We are so grateful for Dr Laxton's care during my recent illness.

4/24/2017

Dr. Laxton is an exceptional physician. He not only is exceptional at what he does, you have no doubt that he cares and has genuine concern for you while he is providing exceptional care. During our first office visit, throughout my stay in the hospital, I had no doubt that I would be taken care of with his help. Dr. Laxton has given me my life back. Trigeminal neuralgia ruled my existence prior to the surgery her performed. I can now play with my 9 year old daughter again and not suffer in pain and be ruled by medicine which was making me sleep all the time. I would recommend him and have to others already. He is a wonderful physician!!

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.